XML 22 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Cash flows from operating activities:          
Net income (loss) $ 7,074 $ (3,946) $ 18,906 $ 8,134  
Adjustments for noncash items:          
Depreciation     15,041 18,372  
Amortization of identifiable intangibles     1,319 1,410  
Reduction of right-of-use lease asset     1,584 1,735  
Deferred income taxes     2,873 2,975  
Accrued pension and post-retirement benefits     134 163  
Stock-based compensation expense     1,759 1,950  
Gain on investment in kaléo     0 (144)  
Gain on the sale of assets     (1,497) 0  
Gain on the sale of divested business 0 0 (9,657) 0 $ 74,900
Changes in assets and liabilities:          
Accounts and other receivables     (23,113) (14,683)  
Inventories     (10,615) (8,711)  
Income taxes recoverable/payable     (111) (952)  
Prepaid expenses and other     5,909 (286)  
Accounts payable and accrued expenses     14,407 (3,454)  
Lease liability     (1,800) (2,118)  
Pension and postretirement benefit plan contributions     (430) (455)  
Other, net     2,559 2,117  
Net cash provided by (used in) operating activities     17,268 6,053  
Cash flows from investing activities:          
Capital expenditures     (9,246) (7,696)  
Proceeds from the sale of Terphane     9,835 0  
Proceeds on sale of investment in kaléo     0 144  
Proceeds from the sale of assets     1,904 83  
Net cash provided by (used in) investing activities     2,493 (7,469)  
Cash flows from financing activities:          
Borrowings     103,747 519,274  
Debt principal payments     (116,173) (522,240)  
Debt financing costs     (1,272) (587)  
Net cash provided by (used in) financing activities     (13,698) (3,553)  
Effect of exchange rate changes on cash     166 (1,898)  
Increase (decrease) in cash and cash equivalents     6,229 (6,867)  
Cash and cash equivalents at beginning of period     7,062 13,455 13,455
Cash and cash equivalents at end of period $ 13,291 $ 6,588 $ 13,291 $ 6,588 $ 7,062